Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (R21NS112779-01A1)
  • Foundation for the National Institutes of Health (R21NS112779-01A1)
  • National Institute of Neurological Disorders and Stroke (R21NS112779-01A1)

This publication has 60 references indexed in Scilit: